Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Stupp

Showing results (21-30 of 313) with videos related to

Pageof 32
Sort By:
Current Oncology Reports|February 9, 2006
Correlative studies in neuro-oncology trials: should they influence treatment?Monika E Hegi, Roger Stupp
Seminars in Oncology|February 7, 2004
Radiotherapy in low-grade gliomas: ConsRené O Mirimanoff, Roger Stupp
Nature Reviews. Neurology|July 3, 2013
Neuro-oncology: in search of molecular markers of glioma in elderly patientsMonika E Hegi, Roger Stupp
Nature Reviews. Clinical Oncology|January 9, 2013
Brain cancer in 2012: Molecular characterization leads the wayRoger Stupp, Monika E Hegi
Onkologie|June 13, 2008
Management of malignant glioma--quo vadis?Roger Stupp, Andreas F Hottinger
The Lancet. Oncology|March 5, 2026
20 years of the Stupp protocol: confronting stagnation in glioblastoma therapyMustafa Khasraw, Emma Pristo, Roger Stupp
The Lancet. Oncology|September 1, 2012
Epilepsy meets cancer: when, why, and what to do about it?Michael Weller, Roger Stupp, Wolfgang Wick
Neuro-Oncology|April 8, 2021
MGMT promoter methylation is associated with patient age and 1p/19q status in IDH-mutant gliomasCraig Horbinski, Kathleen McCortney, Roger Stupp
Acta Neurologica Belgica|February 26, 2009
Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomideBart Neyns, Anne Hoorens, Roger Stupp
Chinese Clinical Oncology|April 6, 2015
The changing world of drug development: an academic research organization's perspective on the "Seven Wonders" of the future world of anticancer drug developmentYan Liu, Denis Lacombe, Roger Stupp
Pageof 32

Showing results (21-30 of 313) with videos related to

Sort By:
Pageof 32
Current Oncology Reports|February 9, 2006
Correlative studies in neuro-oncology trials: should they influence treatment?Monika E Hegi, Roger Stupp
Seminars in Oncology|February 7, 2004
Radiotherapy in low-grade gliomas: ConsRené O Mirimanoff, Roger Stupp
Nature Reviews. Neurology|July 3, 2013
Neuro-oncology: in search of molecular markers of glioma in elderly patientsMonika E Hegi, Roger Stupp
Nature Reviews. Clinical Oncology|January 9, 2013
Brain cancer in 2012: Molecular characterization leads the wayRoger Stupp, Monika E Hegi
Onkologie|June 13, 2008
Management of malignant glioma--quo vadis?Roger Stupp, Andreas F Hottinger
The Lancet. Oncology|March 5, 2026
20 years of the Stupp protocol: confronting stagnation in glioblastoma therapyMustafa Khasraw, Emma Pristo, Roger Stupp
The Lancet. Oncology|September 1, 2012
Epilepsy meets cancer: when, why, and what to do about it?Michael Weller, Roger Stupp, Wolfgang Wick
Neuro-Oncology|April 8, 2021
MGMT promoter methylation is associated with patient age and 1p/19q status in IDH-mutant gliomasCraig Horbinski, Kathleen McCortney, Roger Stupp
Acta Neurologica Belgica|February 26, 2009
Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomideBart Neyns, Anne Hoorens, Roger Stupp
Chinese Clinical Oncology|April 6, 2015
The changing world of drug development: an academic research organization's perspective on the "Seven Wonders" of the future world of anticancer drug developmentYan Liu, Denis Lacombe, Roger Stupp
Pageof 32